A Phase I Study of Famitinib Malate in Patients With Solid Tumor

NCT01762280 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Famitinib Malate Capsule

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]
[object Object]